Journal: bioRxiv
Article Title: IL-32 drives inflammatory responses in IFN-γ primed human macrophages via a Myddosome-dependent pathway and is elevated in COVID-19
doi: 10.1101/2025.05.29.656795
Figure Lengend Snippet: (A) UMAP projection schematics of the cell populations examined by single-cell sequencing ( > 300,000 single-cell profiles) from multiple inflammatory diseases and COVID-19 BALF. (B) Expression levels of the IL32, IRAK1, IFNG, IFNGR1, IFNGR2 genes in sc-RNAseq datasets from multiple inflammatory diseases and COVID-19. (C) Detection of IL-32 protein by ELISA in serum samples from healthy donors and patients with mild and severe COVID-19. Statistical analysis: data shown in (C) are mean values of healthy individuals, HC (n = 16), mild (n = 25) and severe (n = 59) COVID-19 with non-parametric Kruskal-Wallis test with Dunn’s multiple comparisons test vs HC (** p < 0.005, *** p < 0.001).
Article Snippet: The coverslips were then transferred to a humid chamber and incubated with primary antibodies for detection of protein components in the Myddosome: MyD88 (Thermo Fisher, PA5-19919), IRAK1 (CST, 4359), IKKγ/NEMO (Thermo Fisher, MA5-32682) and TAK1/MAP3K7 (Thermo Fisher, 700113) in blocking solution for 1 h at RT.
Techniques: Sequencing, Expressing, Enzyme-linked Immunosorbent Assay